76
68. Fiaccadori E, Del Canale S, Coffrini E et al. (1988) Muscle and serum magnesium in pulmonary intensive care unit patients. Crit Care Med; 16: 75160.
69. Zofkova I, Kancheva RL: (1995) The relationship between magnesium and calciotrophic hormones (abstract). Magnes Res; 8;77-84.
70. Reinhart RA. (1998) Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. Arch Int Med; 148:2415-20.
71. Zwillinger L: (1995) On magnesium’s effects on the heart. Klin Wochenschr 14:142933.
72. Salem M, Stacey J, Chernow B. (1993) Ionized magnesium values in critically ill patients a novel ion selective electrode for determining free extracellular magnesium concentrations. Crit Care Med;21(4): (Supplement) S256.
73. Ely EW, Margolin R, Francis J, et al. (2001) Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method fort he Intensive Care Unit (CAM-ICU) Crit Care Med ;29:1370-1379. Further details available @ www.icudelirium.org/delirium
74. James MFM, Beer RE, Esser JD: (1989) Intravenous magnesium sulphate inhibits catecholamine release associated with tracheal intubation. Anesth Analg; 68:772-6.
75. Bloch H, Silverman R, Mancherje N et al: (1995) Intravenous magnesium sulfate as an adjunt in the treatment of acute asthma. Chest; 107: 1576-81.
76. Abu-Osba YK, Galal O, Manasra K, Rejjal A: (1992) Treatment of severe persistent pulmonary hypertension of the new-born with magnesium sulphate. Arch Dis Child; 67:31-5.
77. Kaya M, Küçük M, Kalaycı RV, et al: (2001) Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglcemia in rats. Can J Phsysiol Pharmacol; 79:793-8



85. SAYFADAKI ANAHTAR KELIMELER

care
patients
with
critically
intensive
crit


85. SAYFA ICERIGI

76
68. Fiaccadori E, Del Canale S, Coffrini E et al. (1988) Muscle and serum magnesium in pulmonary intensive care unit patients. Crit Care Med; 16: 75160.
69. Zofkova I, Kancheva RL: (1995) The relationship between magnesium and calciotrophic hormones (abstract). Magnes Res; 8;77-84.
70. Reinhart RA. (1998) Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. Arch Int Med; 148:2415-20.
71. Zwillinger L: (1995) On magnesium’s effects on the heart. Klin Wochenschr 14:142933.
72. Salem M, Stacey J, Chernow B. (1993) Ionized magnesium values in critically ill patients a novel ion selective electrode for determining free extracellular magnesium concentrations. Crit Care Med;21(4): (Supplement) S256.
73. Ely EW, Margolin R, Francis J, et al. (2001) Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method fort he Intensive Care Unit (CAM-ICU) Crit Care Med ;29:1370-1379. Further details available @ www.icudelirium.org/delirium
74. James MFM, Beer RE, Esser JD: (1989) Intravenous magnesium sulphate inhibits catecholamine release associated with tracheal intubation. Anesth Analg; 68:772-6.
75. Bloch H, Silverman R, Mancherje N et al: (1995) Intravenous magnesium sulfate as an adjunt in the treatment of acute asthma. Chest; 107: 1576-81.
76. Abu-Osba YK, Galal O, Manasra K, Rejjal A: (1992) Treatment of severe persistent pulmonary hypertension of the new-born with magnesium sulphate. Arch Dis Child; 67:31-5.
77. Kaya M, Küçük M, Kalaycı RV, et al: (2001) Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglcemia in rats. Can J Phsysiol Pharmacol; 79:793-8

İlgili Kaynaklar







single.php